Aimei Health receives Nasdaq delisting notices for MVLS and MVPHS below thresholds

Aimei Health Technology Co., Ltd.

On Aug 21, 2026, Nasdaq notified Aimei that Market Value of Listed Securities (MVLS) was below $50M for 30 consecutive business days.
Same date, Nasdaq notified that Market Value of Publicly Held Shares (MVPHS) was below $15M for 30 consecutive business days.
Compliance period extends 180 calendar days to Feb 17, 2027, to regain compliance with either or both requirements.
Compliance can be regained if MVLS closes at or above $50M and MVPHS at or above $15M for 10 consecutive business days.
Company may consider transferring to Nasdaq Capital Market if requirements are not met by deadline.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.